Navigation Links
Best code for disease detection, bar none
Date:6/18/2008

Malaria and dengue fever will be the early targets of new trans-Pacific research using minuscule "barcodes" to detect disease.

The University of Queensland (UQ) and the University of Washington (UW) are poised to launch the research after Queensland Premier Anna Bligh announced $650,000 from the National and International Research Alliances Program on June 18.

"Detection of the pathogens of two debilitating mosquito-borne diseases, malaria and dengue fever, is just the first target of this research," UQ Vice-Chancellor Professor Paul Greenfield said as he welcomed the funding.

"Down the track the results are likely to have widespread applications in medicine, biosecurity, pharmaceuticals and agriculture.

"The researchers are pioneers of 'nano-barcodes', from which they take electronic read-outs of information about targeted molecules.

"The read-outs are analogous to incredibly detailed inventories of molecules.

"The practical outcome is a diagnostic tool that is cheaper, more sensitive, more accurate and easier to use than established techniques."

The research team comprises Dr Krassen Dimitrov, a scientist-entrepreneur at UQ's Australian Institute for Bioengineering and Nanotechnology who was formerly at UW, Seattle, along with Dr Daniel T Schwartz and Dr Karl Boehringer, both of UW.

UQ Deputy Vice-Chancellor (Research) Professor David Siddle thanked UW, which is contributing $900,000 (from Washington State's Life Science Discovery Fund) to the two-year $1.8 million project.

"This project will demonstrate the potential of teamwork between UQ and UW. We signed an agreement for cultural, educational and scientific cooperation in 2006 and we launched the $450,000 Trans-Pacific Fellowships this month (June 2008)," Professor Siddle said.

"The governments of Queensland and Washington have significant ties and are supportive of collaborative research."


'/>"/>

Contact: Fiona Kennedy
communications@uq.edu.au
61-733-656-060
Research Australia
Source:Eurekalert

Page: 1

Related biology news :

1. New discoveries from Harvard and Baylor get to the heart of cardiovascular disease
2. Geisinger study: Inflammatory disease causes blindness
3. Gladstone and Izumi Bio in partnership in regenerative medicine and cardiovascular disease
4. Europe-wide investment in lipid research will help tackle disease, says new report
5. Mechanism explains link between apolipoprotein E and Alzheimers disease
6. A protein sequence associated with Huntington’s disease may become life-saving vaccine component
7. BWF awards $7 million to infectious disease investigators
8. Microbial stowaways: Are ships spreading disease?
9. New cheaper method for mapping disease genes
10. Neural cell transplants may help those with Parkinsons disease
11. Observations from space: NASA environmental data and lung disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/28/2016)... -- "The biometric system market projected ... biometric system market is in the growth stage and ... The biometric system market is expected to be valued ... of 16.79% between 2016 and 2022. Government initiative in ... smartphones, rising use of biometric technology in financial institutes ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... CALGARY , Dec. 5, 2016 /PRNewswire/ - ... announced  that the independent Data and Safety Monitoring ... trial in high-risk cardiovascular disease (CVD) patients has ... that the study should continue as planned without ... and noted that no safety or efficacy concerns ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/5/2016)... -- The U.S. Biotechnology industry is the ... revenue and some $890 billion of total market value. In ... and this figure is expected to exceed $220 billion ... four equities for assessment: Northwest Biotherapeutics Inc. (NASDAQ: ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ACOR ...
(Date:12/4/2016)... ... 03, 2016 , ... Microbial genomics leader uBiome is awarding ... been made to Dr. Renato Polimanti of Yale University School of Medicine, who ... Grant proposals have been vetted by the company’s scientific review committee. , ...
Breaking Biology Technology: